Enseval Putera Megatrading Tbk PT
IDX:EPMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Enseval Putera Megatrading Tbk PT
Income from Continuing Operations
Enseval Putera Megatrading Tbk PT
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
Income from Continuing Operations
Rp787B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Dosni Roha Indonesia Tbk PT
IDX:ZBRA
|
Income from Continuing Operations
-Rp325B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-190%
|
CAGR 10-Years
-48%
|
|
|
I
|
Itama Ranoraya PT
IDX:IRRA
|
Income from Continuing Operations
Rp65.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Millennium Pharmacon International Tbk PT
IDX:SDPC
|
Income from Continuing Operations
Rp38.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
69%
|
CAGR 10-Years
12%
|
|
|
P
|
PT UBC Medical Indonesia Tbk
IDX:LABS
|
Income from Continuing Operations
Rp13.5B
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Enseval Putera Megatrading Tbk PT
Glance View
PT Enseval Putera Megatrading Tbk engages in the distribution and supply of pharmaceutical, consumer, medical equipment, cosmetics and other trading products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 5,000 full-time employees. The firm is engaged in trading and distribution of consumer products and medical devices. The firm focuses its activities on distribution and trading services through four divisions: pharmaceutical products, consumer products, medical devices and chemical products. The company provides services across digital platform, distribution and sales, health care, marketing and logistics. The company offers a range of products, such as consumer product, prescription and non-prescription medicines, raw materials, medical devices, clinics and veterinary products. Its subsidiaries include PT Tri Sapta Jaya, which distributes pharmaceutical and medical equipment; PT Millenia Dharma Insani, which operates clinics under the brand name of Mitrasana; PT Enseval Medika Prima, which focuses on trading of medical devices, and PT Renalmed Tiara Utama, which supplies materials and hemodialysis machines.
See Also
What is Enseval Putera Megatrading Tbk PT's Income from Continuing Operations?
Income from Continuing Operations
787B
IDR
Based on the financial report for Dec 31, 2025, Enseval Putera Megatrading Tbk PT's Income from Continuing Operations amounts to 787B IDR.
What is Enseval Putera Megatrading Tbk PT's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
4%
Over the last year, the Income from Continuing Operations growth was 7%. The average annual Income from Continuing Operations growth rates for Enseval Putera Megatrading Tbk PT have been -2% over the past three years , 3% over the past five years , and 4% over the past ten years .